{ "items": [ "\n\n
\n \n 15 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Kerstin Timm in the Department of Pharmacology has been announced as one of the latest round of PIs to secure an AMS Springboard Award. The AMS Springboard award is highly competitive and is intended for new independent researchers in biomedical sciences, who have been in their role for less than 4 years and have not received more than \u00a3150,000 in grant money. The Springboard award thus allows new PIs to launch a new independent program of research, and awards are made for up to \u00a3100,000 over 2 years.
\n \n\n\n \n 15 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nA new book is published this week by Oxford University Press written by Associate Professor John Parrington. \u2018Mind Shift\u2019 draws on new scientific evidence to offer a substantive material explanation of self-conscious awareness in humans.
\n \n\n\n \n 13 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 9 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Vasudevan Group\n \n \n\n \n\n\n
\n \n\n \n \n \nIn collaboration with the infectious disease units at the John Radcliffe and Churchill Hospitals, the Vasudevan lab has identified a novel means of improving RT-qPCR sensitivity and efficiency for the detection of SARS-CoV-2 through the concentration of pooled patient lysates.
\n \n\n\n \n 18 March 2021\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 13 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nAn international collaboration of the Potter Group with Solomon Snyder\u2019s Group in the USA and with Chinese and German colleagues has uncovered the myo-inositol polyphosphate pyrophosphate 5-InsP7 as a regulator of the Na\u207a/K\u207a- ATPase-\u03b11
\n \n\n\n \n 15 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Russell Group\n \n \n\n \n\n\n
\n \n\n \n \n \nAngela Russell, Professor of Medicinal Chemistry in the Oxford Departments of Pharmacology and Chemistry, has been announced as one of the five recipients of the inaugural UK Rare Disease Scholar Award, presented by the Harrington Discovery Institute (HDI).
\n \n\n\n \n 1 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Fran Platt has been appointed as the new Head of Department for Pharmacology at the University of Oxford. Fran took up her new post with effect from 1 June 2020 and will serve for an initial period of five years.
\n \n\n\n \n 17 August 2020\n \n
\n\n \n \n \n\n \n \n \nThe Vascular Pharmacology group has published a paper in Hypertension showing that loss of nitric oxide production by endothelial cells, a ubiquitous feature of cardiovascular disease, raises the electrical excitability of arterial smooth muscle by recruiting T-type voltage-gated calcium channels. This change switches physiological vasomotion to pathological vasospasm.
\n \n\n\n \n 12 August 2020\n \n
\n\n \n\n \n\n \n \n \n \n Ellender Group\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 11 August 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nThis summer three of the world\u2019s most distinguished neurochemists died; each was a member of the Department during their outstanding scientific careers.
\n \n\n\n \n 4 August 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nThere is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson\u2019s disease (PD).
\n \n\n\n \n 3 August 2020\n \n
\n\n \n \n \n\n \n \n \nResearch led by Associate Professor Rebecca Burton at Oxford, together with Associate Professor Gil Bub at McGill University (Canada) and Professor Emilia Entcheva at George Washington University (USA), has demonstrated a purely optical method that makes it possible to stimulate cells and to directly observe both the effects of spatial distribution and functional connectivity between neurons and heart muscle cells. This model system provides a unique window into the relationship between the tissue health, neuron density and the excitability of the heart muscle. These insights are particularly relevant to understanding complications that arise after damage to the heart tissue, such as potentially lethal heart arrhythmias after a heart attack.
\n \n\n\n \n 27 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n Ellender Group\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 14 July 2020\n \n
\n\n \n \n \n\n \n \n \n \n \n\n\n \n 9 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Galione Lab has a paper published in The EMBO Journal showing that local Ca2+\u2010nanodomains formed by two\u2010pore channels (TPCs) on endo-lysosomes are shown to drive phagocytosis in macrophages. Moreover, different endo-lysosomal Ca2+ channels do different jobs at phagocytosis (extreme compartmentation).
\n \n\n\n \n 4 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 19 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nDaniel Anthony, Professor of Experimental Neuropathology in the Department of Pharmacology, is the scientific lead in a joint research team running a new clinical trial to evaluate the effectiveness for the treatment of COVID-19 of Nafamostat. This existing medicine, manufactured by Nichi-Iko Pharmaceutical Co Ltd, is a well-established treatment in Japan for pancreatitis. The company has generously donated supplies of Nafamostat for the initial clinical evaluation.
\n \n\n\n \n 18 May 2020\n \n
\n\n \n \n \n\n \n \n \nThe Vasudevan laboratory, in an interdisciplinary project with scientists and clinicians, across the Department of Psychiatry, Nuffield Department of Clinical Neuroscience, Warneford Hospital, Department of Pathology, Weatherall Institute of Molecular Medicine, and the Oxford StemBANCC, have used bipolar patient-derived fibroblasts to gain a deeper understanding into patient circadian rhythms, and how these rhythmic changes could predict lithium sensitivity in bipolar disorder.
\n \n\n\n \n 11 May 2020\n \n
\n\n \n \n \n\n \n \n \nThe Minichiello laboratory through an excellent interdisciplinary collaborative effort, particularly with the laboratories of Prof E. Cherubini at the European Brain Research Institute (EBRI) in Rome, Italy, and Prof JM. Delgado-Garc\u00eda at the University Pablo de Olavide, Seville, Spain, have now uncovered a novel essential role for BDNF-TrkB signalling in driving sequential maturation of intrinsic hippocampal circuits. They show the in vivo consequences of Ntrk2/Trkb selective deletion at a time-sensitive window both on postnatal development and adult brain.
\n \n\n